REARDON ANDREW (CLO & Secretary) sold 2.9% of their position (1K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $104.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/2/2025ACC: 0002001011-25-000037
Officer· CLO & Secretary
Since Mar 2026
-1.90K
Net shares
Net seller
$193.8K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
1.90K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−897.00
Price / share
$100.16
Trade value
$89.84K
% of position
4.0%
8/10/2024
22.53K→21.64K
Common Stock
Direct
Shares
−1K
Price / share
$104.00
Trade value
$104K
% of position
2.9%
5/15/2025
33.90K→32.90K
Total
Net shares
−1.90K
Net value
-$193.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2024 | F · Tax Withholding | −897.00 | $100.16 | $89.84K | 4.0% | 22.53K | 21.64K |
| Common Stock Direct | 5/15/2025 | S · Sale | −1K | $104.00 | $104K | 2.9% | 33.90K | 32.90K |
| Total | −1.90K | -$193.84K | ||||||
Derivative Transactions0
No derivative transactions reported